Deep Health AI India Limited submitted a regulatory filing to BSE Limited regarding the deferment of a board meeting agenda item. This communication follows a prior intimation dated May 22, 2026, regarding a Board of Directors meeting.
The Board of Directors meeting was held on May 27, 2026. During this meeting, the board decided to defer the agenda item pertaining to the consideration and approval of the Audited Standalone and Consolidated Financial Results for the Financial Year ended March 31, 2026. The Draft Statutory Auditor's Report on these results was also deferred.
This deferment is pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The reason cited for the deferment is paucity of time and the need to seek certain further clarifications from the Management. As a result, the financial results could not be considered and approved at the May 27th meeting.
The matter has been rescheduled and will now be taken up for consideration on Friday, May 29, 2026.
The Board Meeting commenced at 02:00 PM and concluded at 09:50 PM on May 27, 2026.